Sector Watch: Healthcare - Sep 05 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $120.56 -0.44 -0.36% | XBI: $99.24 -0.77 -0.77% | Updated Sep 05, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| PRQR52WH ProQR Therapeutics $560.2M |
17.55+9.60 5.7 M 65.5x |
121% | ||
| VCEL Vericel $591.8M |
13.85+2.20 2.6 M 3.1x |
19% | ||
| IMMP Immutep $81.6M |
2.90+0.31 372.9 K 6.8x |
12% | ||
| REPH Recro Pharma $186.9M |
9.02+0.95 1.0 M 6.4x |
12% | ||
| VVUS VIVUS $63.2M |
0.59+0.05 261.9 K |
9% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| SGMO Sangamo BioSciences $1.5B |
14.55-4.50 11.7 M 5.0x |
-24% | ||
| INCR INC Research Holdings $145.9M |
180.00-43.00 4.1 M 3.1x |
-19% | ||
| BLFS BioLife Solutions $360.3M |
20.14-3.31 932.2 K 2.9x |
-14% | ||
| AMPE Ampio Pharmaceuticals $56.5M |
0.53-0.08 2.3 M |
-13% | ||
| CCM Concord Medical Services Holdings $131.8M |
3.04-0.44 3.6 K |
-13% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
CLASS ACTION UPDATE for AMPE, LCI and ZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial Nasdaq:PRQR [globenewswire.com]
Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018 Nasdaq:REPH [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, RMTI, ORCL, AMPE and CBS [globenewswire.com]
Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals | Business & Finance | heraldchronicle.com [prnewswire.com]
Recro Pharma Provides Regulatory Update for IV Meloxicam Nasdaq:REPH [globenewswire.com]
Progress Towards Clinical Development of IMP761 ? a LAG-3 Agonist Antibody [globenewswire.com]
AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm ? AMPE | Business Wire [businesswire.com]
Pomerantz Law Firm Announces the Filing of a Class Action against Ampio Pharmaceuticals, Inc. and Certain Officers ? AMPE [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LOGM, AMPE, LCI, CBS and PZZA [globenewswire.com]
CLASS ACTION UPDATE for LOGM and AMPE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
Robbins Arroyo LLP: Ampio Pharmaceuticals, Inc. (AMPE) Misled Shareholders According to a Recently Filed Class Action | Business Wire [businesswire.com]
AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm ? AMPE | Business & Finance | heraldchronicle.com [businesswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FB, SBGI, TSLA and AMPE [globenewswire.com]
The Alliance for Regenerative Medicine Releases Agenda for 2018 Cell & Gene Meeting on the Mesa [globenewswire.com]
CLASS ACTION UPDATE for AMPE and NVRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
VIVUS Reports Data Supporting the Cardiovascular Safety of Qsymia® [globenewswire.com]
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm [prnewswire.com]
BioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million Investment [prnewswire.com]
Ampio Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE [prnewswire.com]
Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
